346 related articles for article (PubMed ID: 23398607)
21. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.
Pelz RK; Lipsett PA; Swoboda SM; Diener-West M; Powe NR; Brower RG; Perl TM; Hammond JM; Hendrix CW
Intensive Care Med; 2002 Jun; 28(6):692-7. PubMed ID: 12107672
[TBL] [Abstract][Full Text] [Related]
22. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy.
Suppli M; Aabenhus R; Harboe ZB; Andersen LP; Tvede M; Jensen JU
Clin Microbiol Infect; 2011 Jul; 17(7):1078-83. PubMed ID: 20946408
[TBL] [Abstract][Full Text] [Related]
23. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
[TBL] [Abstract][Full Text] [Related]
24. The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
Jiang HL; Zhou Z; Wang LS; Fang Y; Li YH; Chu CI
Int J Infect Dis; 2017 Jan; 54():18-24. PubMed ID: 27836794
[TBL] [Abstract][Full Text] [Related]
25. Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay.
Lloyd-Smith P; Younger J; Lloyd-Smith E; Green H; Leung V; Romney MG
J Hosp Infect; 2013 Sep; 85(1):54-9. PubMed ID: 23920443
[TBL] [Abstract][Full Text] [Related]
26. Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria.
Khair HN; VanTassell P; Henderson JP; Warren DK; Marschall J;
J Hosp Infect; 2013 Nov; 85(3):183-8. PubMed ID: 23998947
[TBL] [Abstract][Full Text] [Related]
27. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
Forrest GN; Arnold RS; Gammie JS; Gilliam BL
J Infect; 2011 Dec; 63(6):420-8. PubMed ID: 21920382
[TBL] [Abstract][Full Text] [Related]
28. β-lactam antibiotics vs. vancomycin for the early treatment of enterococcal bacteraemia: A retrospective cohort study.
Petersiel N; Bitterman R; Manaa A; Nashashibi L; Moskovich O; Geffen Y; Polak D; Braun E; Neuberger A; Paul M
Int J Antimicrob Agents; 2019 Jun; 53(6):761-766. PubMed ID: 30954636
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission.
Kim YJ; Kim SI; Kim YR; Lee JY; Park YJ; Kang MW
Am J Infect Control; 2012 Dec; 40(10):1018-9. PubMed ID: 22483236
[TBL] [Abstract][Full Text] [Related]
30. Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study.
Gouliouris T; Warne B; Cartwright EJP; Bedford L; Weerasuriya CK; Raven KE; Brown NM; Török ME; Limmathurotsakul D; Peacock SJ
J Antimicrob Chemother; 2018 Jun; 73(6):1692-1699. PubMed ID: 29548009
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.
McBride SJ; Upton A; Roberts SA
Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):107-14. PubMed ID: 19916034
[TBL] [Abstract][Full Text] [Related]
32. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
[TBL] [Abstract][Full Text] [Related]
33. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group.
Mainous MR; Lipsett PA; O'Brien M
Arch Surg; 1997 Jan; 132(1):76-81. PubMed ID: 9006556
[TBL] [Abstract][Full Text] [Related]
34. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
[TBL] [Abstract][Full Text] [Related]
35. Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid.
Santayana EM; Grim SA; Janda WM; Layden JE; Lee TA; Clark NM
Diagn Microbiol Infect Dis; 2012 Sep; 74(1):39-42. PubMed ID: 22749382
[TBL] [Abstract][Full Text] [Related]
36. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
[TBL] [Abstract][Full Text] [Related]
37. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
[TBL] [Abstract][Full Text] [Related]
38. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
Todeschini G; Tecchio C; Borghero C; D'Emilio A; Pegoraro E; de Lalla F; Benedetti P; Spolaore P; Pellizzer G
J Infect; 2006 Oct; 53(4):266-73. PubMed ID: 16388852
[TBL] [Abstract][Full Text] [Related]
39. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
[TBL] [Abstract][Full Text] [Related]
40. Incidence and risk factors of vancomycin-resistant enterococcus colonization in burn unit patients.
Altoparlak U; Koca O; Ozkurt Z; Akcay MN
Burns; 2011 Feb; 37(1):49-53. PubMed ID: 20926196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
